PATENT CLAIM ANALYSIS

Application Number: 15758016
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "007400"]

Abstract:
Disclosed are compositions and methods for the reduction of C5a mediated immune inflammation. The methods, in various aspects, may include the step of administering a C5aR antagonist to a subject in need of such treatment. In one aspect, the subject in need may have a lysosomal acid storage disease. Therapeutic kits and articles of manufacture are also disclosed.

Claim (Index 5):
A method of reducing C5a mediated immune inflammation, comprising the step of administering the composition of  claim 1 , in an amount sufficient to reduce inflammation in a tissue of interest.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 90.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12920293', '13590016', '13505976', '15077256', '13720685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6992966524166307
- 35 USC 102 Novelty (BERT): 0.5121425881561343
- Combined Prediction Score: 0.6805812459905811
- Mean Citation Score: 247.988656
- Max Citation Score: 258.13147000000004
- Similarity Product: 179.1193628417802

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test